SynCore Biotechnology Co.,Ltd reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was TWD 15.86 million compared to TWD 6.94 million a year ago. Net loss was TWD 188.67 million compared to TWD 458.6 million a year ago.

Basic loss per share from continuing operations was TWD 6.1385 compared to TWD 15.1218 a year ago.